Diagnosis: toxic!--trying to apply approaches of clinical diagnostics and prevalence in toxicology considerations.
暂无分享,去创建一个
[1] Allen F. Shaughnessy,et al. Clinical Epidemiology: A Basic Science for Clinical Medicine , 2007, BMJ : British Medical Journal.
[2] E. Murray. Decision making in health and medicine: integrating evidence and values (with CD). Myriam Hunink, Paul Glasziou, Joanna Siegel, Jane Weeks, Joseph Pliskin, Arthur Elstein, Milton Weinstein. (400 pages, £34.95, US$49.95.) Cambridge University Press, 2001. ISBN 0-521-77029-7. , 2002 .
[3] A. Baron,et al. Reference test errors bias the evaluation of diagnostic tests for ischemic heart disease , 1988, Journal of General Internal Medicine.
[4] J J Gart,et al. Comparison of a screening test and a reference test in epidemiologic studies. I. Indices of agreement and their relation to prevalence. , 1966, American journal of epidemiology.
[5] Ebm Notebook,et al. Transferring evidence from research into practice: 1. The role of clinical care research evidence in clinical decisions , 1996, ACP Journal Club.
[6] M Liebsch,et al. The ECVAM International Validation Study on In Vitro Tests for Skin Corrosivity. 2. Results and Evaluation by the Management Team. , 1998, Toxicology in vitro : an international journal published in association with BIBRA.
[7] S C Weller,et al. Assessing Rater Performance without a "Gold Standard" Using Consensus Theory , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.
[8] R. Marshall,et al. The Predictive Value of Simple Rules for Combining Two Diagnostic Tests , 1989 .
[9] C. Gatsonis,et al. Designing studies to ensure that estimates of test accuracy are transferable , 2002, BMJ : British Medical Journal.
[10] Rodger Curren,et al. No Prediction Model, No Validation Study , 1996 .
[11] A P Worth,et al. The Importance of the Prediction Model in the Validation of Alternative Tests , 2001, Alternatives to laboratory animals : ATLA.
[12] F. Drudi,et al. Assessment of the accuracy of diagnostic chest CT scanning. Impact on lung cancer management. , 1996, International surgery.
[13] Allanou Remi,et al. Public Availability of Data on EU High Production Volume Chemicals. Part 1. , 2003 .
[14] K. Schulz,et al. Uses and abuses of screening tests , 2002, The Lancet.
[15] U. Epa,et al. Office of Pollution Prevention and Toxics , 2000 .
[16] L. Dopson. Clinical Expertise , 2007, Nursing times.
[17] B. Ames,et al. Chemical carcinogenesis: too many rodent carcinogens. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[18] D. Sackett,et al. The architecture of diagnostic research , 2002, BMJ : British Medical Journal.
[19] Sac-fry Stages,et al. OECD GUIDELINE FOR TESTING OF CHEMICALS , 2002 .
[20] S D Walter,et al. Meta-analysis of diagnostic tests with imperfect reference standards. , 1999, Journal of clinical epidemiology.
[21] J André Knottnerus,et al. Evaluation of diagnostic procedures , 2002, BMJ : British Medical Journal.
[22] G J Carr,et al. An investigation of new toxicity test method performance in validation studies: 3. sensitivity and specificity are not independent of prevalence or distribution of toxicity , 2002, Human & experimental toxicology.
[23] P. Bossuyt,et al. BMC Medical Research Methodology , 2002 .
[24] Spielmann Horst,et al. Practical Aspects of the Validation of Toxicity Test Procedures , 1995 .
[25] Gordon H Guyatt,et al. Clinical expertise in the era of evidence-based medicine and patient choice , 2002, ACP journal club.
[26] Sebastian Hoffmann,et al. Skin irritation: prevalence, variability, and regulatory classification of existing in vivo data from industrial chemicals. , 2005, Regulatory toxicology and pharmacology : RTP.
[27] L. Bruner,et al. An investigation of new toxicity test method performance in validation studies: 2. comparison of three measures of toxicity test performance , 2002, Human & experimental toxicology.
[28] Michael Balls,et al. Report and Recommendations of the CAAT 1 /ERGATT 2 Workshop on the Validation of Toxicity Test Procedures 3 , 1990 .
[29] M. Weinstein,et al. Decision Making in Health and Medicine , 2001 .
[30] E. Keeler,et al. Primer on certain elements of medical decision making. , 1975, The New England journal of medicine.
[31] G. Guyatt,et al. Clinical expertise in the era of evidence-based medicine and patient choice. , 2002, Vox sanguinis.
[32] J. Knottnerus,et al. Assessment of the accuracy of diagnostic tests: the cross-sectional study. , 2003, Journal of clinical epidemiology.
[33] G. Gigerenzer,et al. AIDS counselling for low-risk clients. , 1998, AIDS care.
[34] B. Ames,et al. What do animal cancer tests tell us about human cancer risk?: Overview of analyses of the carcinogenic potency database. , 1998, Drug metabolism reviews.
[35] Y. T. van der Schouw,et al. Guidelines for the Assessment of New Diagnostic Tests , 1995, Investigative radiology.
[36] H Brenner,et al. Variation of sensitivity, specificity, likelihood ratios and predictive values with disease prevalence. , 1997, Statistics in medicine.
[37] K. Linnet,et al. A review on the methodology for assessing diagnostic tests. , 1988, Clinical chemistry.